Keybanc Upgrades Maravai LifeSciences to Overweight, Announces $11 Price Target
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsUpgradesPrice Target
Keybanc analyst Paul Knight upgrades Maravai LifeSciences (NASDAQ:MRVI) from Sector Weight to Overweight and announces $11 price target.
Keybanc analyst Paul Knight upgrades Maravai LifeSciences (NASDAQ:MRVI) from Sector Weight to Overweight and announces $11 price target.